(Press-News.org) Researchers funded by the Biotechnology and Biological Sciences Research Council have shown one way in which poor nutrition in the womb can put a person at greater risk of developing type 2 diabetes and other age-related diseases in later life. This finding could lead to new ways of identifying people who are at a higher risk of developing these diseases and might open up targets for treatment.
The team, from the University of Cambridge and the Medical Research Council (MRC) Toxicology Unit at the University of Leicester, publish their findings today (Friday 6 January) in the journal Cell Death and Differentiation.
The research shows that, in both rats and humans, individuals who experience a poor diet in the womb are less able to store fats correctly in later life. Storing fats in the right areas of the body is important because otherwise they can accumulate in places like the liver and muscle where they are more likely to lead to disease.
Professor Anne Willis of the MRC Toxicology Unit at the University of Leicester explains "One of the ways that our bodies cope with a rich modern western diet is by storing excess calories in fat cells. When these cells aren't able to absorb the excess then fats get deposited in other places, like the liver, where they are much more dangerous and can lead to type 2 diabetes."
The team found that this process is controlled by a molecule called miR-483-3p. They found that miR-483-3p was produced at higher levels in individuals who had experienced a poor diet in their mother's wombs than those who were better nourished.
When pregnant rats were fed low protein diets their offspring had higher levels of miR-483-3p. This led to them developing smaller fat cells and left them less able to store fats in adulthood. These rats were less likely to get fat when fed a high calorie diet but were at a higher risk of developing diabetes. Rats are known to be a good model for studying human dietary diseases and the team also found that miR-483-3p was present in elevated levels in a group of people who were born with a low birth weight.
Dr Susan Ozanne, a British Heart Foundation Senior Fellow, who led the work at the University of Cambridge, adds "It has been known for a while that your mother's diet during pregnancy plays an important role in your adult health, but the mechanisms in the body that underlie this aren't well understood. We have shown in detail how one mechanism links poor maternal diet to diabetes and other diseases that develop as we age."
Dr Ozanne and Professor Willis and their team found that miR-483-3p works by suppressing a protein called GDF3. When they studied a group of adult humans who were born with a low birth weight, they found that GDF3 protein was present at around only thirty percent of the levels found in people born at a normal weight.
Professor Willis, Director of the MRC Toxicology Unit, adds "Improving people's diets and encouraging exercise is clearly the best way to combat the epidemic of diabetes and diet-related disease which is sweeping through our society. However some people are at particular risk of these diseases, despite not looking visibly overweight. This research will hopefully allow us to help these people to take precautionary steps to reduce their likelihood of developing type 2 diabetes."
Professor Douglas Kell, Chief Executive of BBSRC said "People are continuing to live ever longer and healthier lives thanks to improvements in nutrition and healthcare. However modern diets and lifestyles are posing new challenges to which our bodies sometimes seem poorly adapted – and this has caused unforeseen health problems.
"If we are to remain healthy throughout our lives and into old age it is vital that scientists work to understand our fundamental biology in the context of social and environmental changes. By identifying a mechanism that links maternal diet to diabetes this research has made an important contribution to the fight against a growing epidemic of metabolic diseases."
### END
How poor maternal diet can increase risk of diabetes -- new mechanism discovered
2012-01-09
ELSE PRESS RELEASES FROM THIS DATE:
Mass prostate cancer screening doesn't reduce deaths
2012-01-09
There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.
A longer follow-up of more than 76,000 men in a major U.S. study shows that six years of aggressive, annual screening for prostate cancer led to more diagnoses of tumors but not to fewer deaths from the disease.
The updated results of the Prostate, Lung, Cancer, Colorectal and Ovarian (PLCO) Cancer Screening ...
Differing dangers at sea
2012-01-09
The probability of being killed at work is 25 times higher for a coastal fisherman than for an offshore worker, according to a study from the UiS. Seafarers also run a high risk of accidents.
Fifteen people died on vessels registered in Norway during 2010, figures from the Norwegian Maritime Directorate (NMD) show. Eight of these were fishermen.
Although these statistics show that the number of work accidents went down in 2009-10, the total has remained at a high and stable level for many decades.
The number of accidents in maritime transport has moreover increased ...
Implanted biofuel cell converts bug's chemistry into electricity
2012-01-09
An insect's internal chemicals can be converted to electricity, potentially providing power for sensors, recording devices or to control the bug, a group of researchers at Case Western Reserve University report.
The finding is yet another in a growing list from universities across the country that could bring the creation of insect cyborgs – touted as possible first responders to super spies – out of science fiction and into reality. In this case, the power supply, while small, doesn't rely on movement, light or batteries, just normal feeding.
The work is published ...
Added benefit of linagliptin is not proven
2012-01-09
Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise. It is an option for patients who do not tolerate or should not take the usual treatment with the drug metformin. Moreover, linagliptin can be added if treatment with metformin alone is not sufficient.
In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German ...
Abiraterone: Indication of considerable added benefit in certain patients
2012-01-09
Abiraterone (trade name: Zytiga®) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether abiraterone offers an added benefit compared with the present standard therapy.
IQWiG finds an indication of a considerable added ...
Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
2012-01-09
TAMPA, Fla. (Jan. 6, 2012) – A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
According to corresponding author Dung-Tsa Chen, Ph.D., associate member with the Moffitt Biostatistics program, non-small cell lung cancer (NSCLC) accounts for 80-90 percent of all lung cancers. ...
Hybrid silkworms spin stronger spider silk
2012-01-09
This week, research was published showing that silk produced by transgenically-engineered silkworms in the laboratory of Malcolm Fraser, Jr., professor of biological sciences at University of Notre Dame, exhibits the highly sought-after strength and elasticity of spider silk. This stronger silk could possibly be used to make sutures, artificial limbs and parachutes.
The findings were published in the Proceedings of the National Academy of Sciences and highlighted for their breakthrough in the long search for silk with such mechanical properties. The manuscript was published ...
Mars rover to spend winter at 'Greeley Haven,' named for late ASU geologist Ronald Greeley
2012-01-09
TEMPE, Ariz. - NASA's Mars Exploration Rover Opportunity will spend the next few months during the coldest part of Martian winter at Greeley Haven, an outcrop of rock on Mars recently named informally to honor Ronald Greeley, Arizona State University Regents' professor of planetary geology, who died October 27, 2011.
Long passionate about exploring the solar system and Mars in particular, Greeley was involved with many missions to the Red Planet, including Mariners 6, 7, and 9, Viking, Mars Pathfinder, Mars Global Surveyor, and the two Mars Exploration Rovers. He was ...
Experts offer pointers for optimizing radiation dose in pediatric CT
2012-01-09
An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans. Approximately seven to eight million CT examinations are performed for various pediatric clinical indications per year in the United States.
Justification of clinical indication is the most important aspect of reducing radiation dose with CT scanning. A substantial number of pediatric CT scans lack appropriate justification or can be replaced with other imaging modalities with lower or no ionizing ...
The nuclear, biological and climate threat - 2011 reviewed
2012-01-09
In this special issue of the Bulletin of the Atomic Scientists, published by SAGE, experts reflect on 2011 and highlight what to look out for in 2012 in the areas of nuclear energy, nuclear weapons, biosecurity, and climate change. Topics that have made the headlines during the previous 12 months, including the increased tension surrounding Iran's nuclear programme, the aftermath of the Fukushima incident, and the state of US policy on climate change, are analyzed in detail in this special issue.
At the Doomsday Clock Symposium on January 9-10 in Washington, DC, the Bulletin's ...